Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, PSF, CFG

/R E P E A T -- Notice to the Media - Government of Canada officials to hold a technical briefing on AstraZeneca COVID-19 vaccines/


OTTAWA, ON, April 14, 2021 /CNW/ - Government of Canada officials will hold a technical briefing to provide an update on the AstraZeneca COVID-19 vaccine.

Officials will be available to answer questions from the media following their remarks.

Date
April 14, 2021

Time
11:00 AM (EDT)

Location

The media technical briefing will be held virtually. Media will be able to ask questions via teleconference.

Toll-free (Canada/US) dial-in number:
1-866-206-0153
Local dial-in number:
613-954-9003

Passcode: 1622050#

To obtain the briefing material under embargo, please RSVP by email at [email protected].

NOTE: To help ensure optimal simultaneous interpretation sound quality, journalists are encouraged to use a microphone (headphones/headset) or, when possible, a landline, and to avoid using speaker mode if queuing up for questions.

Twitter: @GovCanHealth
Facebook: Healthy Canadians

SOURCE Health Canada


These press releases may also interest you

at 09:35
Inocras, a leading AI-driven whole genome testing company, proudly announces the launch of CancerVision and RareVision, its flagship whole genome diagnostics solutions in solid tumor cancer and rare disease, respectively. CancerVision and...

at 09:30
PossibleNOWtm, the leading provider of enterprise consent and preference management solutions, today announced the launch of a program to enable companies to quickly capture express written consent. This will provide the ability for Third-Party...

at 09:30
Envisagenics, an AI-driven biotechnology company, today announced the publication in the journal Molecular Systems Biology of study results evaluating the company's SpliceCore AI/ML platform in Triple Negative Breast Cancer (TNBC). This study...

at 09:30
Co-Diagnostics, Inc. , a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first quarter 2024 financial results on Thursday, May 9, 2024, after the...

at 09:20
Coronis Health, a trusted partner for laboratory and pathology revenue cycle management (RCM), will be a leading voice at the upcoming Executive War College (EWC) 2024 conference from April 30 to May 1 in New Orleans. As the premier forum for...

at 09:18
PRUVN Research LLC, [PRUVN], a leading research organization validating wellness products and services, is excited to announce the results of its recent preliminary study with Max International, investigating the impact of RiboCeinetm supplementation...



News published on and distributed by: